Christoph Reiners

Prof. Dr. Christoph Reiners

Medical Faculty, University of Würzburg, Würzburg 97078, Germany;
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2020 in Journal of Neural Transmission
Verified
Journal Article
Open access
PDF file
Christoph ReinersChristoph Reiners
Christoph Reiners
VDValentina Drozd
Valentina Drozd
SYShunichi Yamashita
Shunichi Yamashita
The thyroid gland is among the organs at the greatest risk of cancer from ionizing radiation. Epidemiological evidence from survivors of radiation therapy, atomic bombing, and the Chernobyl reactor accident, clearly shows that radiation exposure in childhood can cause thyroid cancer and benign thyroid nodules. Radiation exposure also may induce hypothyroidism and autoimmune reactions against the thyroid, but these effects are less well-documented. The literature includes only a few, methodologically weak animal studies regarding genetic/molecular mechanisms underlying hypothyroidism and thyroid autoimmunity after radiation exposure. Rather, evidence about radiation-induced hypothyroidism and thyroid autoimmunity derives mainly from follow-up studies in patients treated with external beam radiotherapy (EBRT) or iodine-131, and from epidemiological studies in the atomic bombing or nuclear accident survivors. Historically, hypothyroidism after external irradiation of the thyroid in adulthood was considered not to develop below a 10–20 Gy dose threshold. Newer data suggest a 10 Gy threshold after EBRT. By contrast, data from patients after iodine-131 “internal radiation therapy” of Graves´ disease indicate that hypothyroidism rarely occurs below thyroid doses of 50 Gy. Studies in children affected by the Chernobyl accident indicate that the dose threshold for hypothyroidism may be considerably lower, 3–5 Gy, aligning with observations in A-bomb survivors exposed as children. The reasons for these dose differences in radiosensitivity are not fully understood. Other important questions about the development of hypothyroidism after radiation exposure e.g., in utero, about the interaction between autoimmunity and hypofunction, and about the different effects of internal and external irradiation still must be answered.

1 April 2015 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
CLConstantin Lapa
Constantin Lapa
RWRudolf A. Werner
Rudolf A. Werner
JSJan-Stefan Schmid
Jan-Stefan Schmid
László PappLászló Papp
László Papp
NZNorbert Zsótér
Norbert Zsótér
Ralph Alexander BundschuhRalph Alexander Bundschuh
Ralph Alexander Bundschuh

1 November 2012 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
RSRita Schneider
Rita Schneider
MSMara Schneider
Mara Schneider
Christoph ReinersChristoph Reiners
Christoph Reiners
PSPeter Schneider
Peter Schneider
Previous studies of the effects of levothyroxine (LT(4)) therapy on bone and bone metabolism have provided conflicting results.

Valentina DrozdValentina Drozd
Valentina Drozd
VSVladimir Saenko
Vladimir Saenko
DBDaniel I. Branovan
Daniel I. Branovan
KBKate Brown
Kate Brown
SYShunichi Yamashita
Shunichi Yamashita
Christoph ReinersChristoph Reiners
Christoph Reiners
The incidence of differentiated thyroid cancer (DTC) is steadily increasing globally. Epidemiologists usually explain this global upsurge as the result of new diagnostic modalities, screening and overdiagnosis as well as results of lifestyle changes including obesity and comorbidity. However, there is evidence that there is a real increase of DTC incidence worldwide in all age groups. Here, we review studies on pediatric DTC after nuclear accidents in Belarus after Chernobyl and Japan after Fukushima as compared to cohorts without radiation exposure of those two countries. According to the Chernobyl data, radiation-induced DTC may be characterized by a lag time of 4–5 years until detection, a higher incidence in boys, in children of youngest age, extrathyroidal extension and distant metastases. Radiation doses to the thyroid were considerably lower by appr. two orders of magnitude in children and adolescents exposed to Fukushima as compared to Chernobyl. In DTC patients detected after Fukushima by population-based screening, most of those characteristics were not reported, which can be taken as proof against the hypothesis, that radiation is the (main) cause of those tumors. However, roughly 80% of the Fukushima cases presented with tumor stages higher than microcarcinomas pT1a and 80% with lymph node metastases pN1. Mortality rates in pediatric DTC patients are generally very low, even at higher tumor stages. However, those cases considered to be clinically relevant should be followed-up carefully after treatment because of the risk of recurrencies which is expected to be not negligible. Considering that thyroid doses from the Fukushima accident were quite small, it makes sense to assess the role of other environmental and lifestyle-related factors in thyroid carcinogenesis. Well-designed studies with assessment of radiation doses from medical procedures and exposure to confounders/modifiers from the environment as e.g., nitrate are required to quantify their combined effect on thyroid cancer risk.

1 February 2018 in Thyroid®
Verified
Journal Article
Closed access
CBCarolien M. Beukhof
Carolien M. Beukhof
EMElske Theresia Massolt
Elske Theresia Massolt
TVTheo J. Visser
Theo J. Visser
TKTim I.M. Korevaar
Tim I.M. Korevaar
MMMarco Medici
Marco Medici
RPRobin P. Peeters
Robin P. Peeters
Background: Subclinical hypothyroidism is associated with dyslipidemia and atherosclerosis. Whether part of these effects are mediated via direct effects of TSH on peripheral TH metabolism and/or concentrations of serum lipids is not clear. Objective: To examine whether thyroid stimulating hormone (TSH) has direct effects on peripheral thyroid hormone (TH) metabolism and serum lipids. Methods: We retrospectively analyzed 82 patients with differentiated thyroid cancer. All patients had undergone total thyroidectomy and 131I remnant ablation. During follow-up, two successive injections of recombinant human TSH (rhTSH) were administered in patients on a stable dose of levothyroxine. In all patients, TSH, thyroxine (T4), free T4 (FT4), triiodothyronine (T3), reverse T3 (rT3), total cholesterol, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein B (apoB), lipoprotein(a) [Lp(a)] and triglyceride levels were measured immediately before the first, and approximately 72 hours after the second injection of rhTSH. Results: After rhTSH stimulation, T3 values decreased (from 1.91 to 1.81 nmol/l, p<0.001). T4, FT4 and rT3 did not change. After rhTSH, median apoB increased from 0.90 to 0.92 g/l (p=0.03), Lp(a) from 0.21 to 0.24 g/l (p<0.001) and triglycerides from 1.98 to 2.50 mmol/l (p<0.001). Serum HDL-C decreased from 0.98 to 0.81 mmol/l (p<0.001). Multiple regression analysis showed that the changes in lipids could be attributed to the decrease in T3 levels. Conclusions: TSH has direct effects on peripheral TH metabolism by decreasing T3 levels in levothyroxine-treated thyroidectomized patients. This decrease in T3 levels is accompanied by unfavorable changes in serum lipids.

8 July 2021 in Thyroid®
Verified
Journal Article
Closed access
EVEvert F.S. van Velsen
Evert F.S. van Velsen
WVW. Edward Visser
W. Edward Visser
MSMerel Tessa Stegenga
Merel Tessa Stegenga
UMUwe Maeder
Uwe Maeder
Christoph ReinersChristoph Reiners
Christoph Reiners
RPRobin P. Peeters
Robin P. Peeters
Background: Differentiated thyroid cancer (DTC) is the only cancer entity for which the UICC/AJCC (Union for International Cancer Control and American Joint Committee on Cancer) TNM (tumor–node–metastasis) staging system involves an age cutoff as a prognostic criterion. However, the optimal age cutoff has not yet been determined in detail. The aim of our study was therefore to investigate the optimal age cutoff for the TNM staging system to predict disease-specific survival (DSS) with a focus on differences between patients with papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC). Methods: We retrospectively studied two large well-described cohorts of adult DTC patients from a Dutch and a German university hospital. DSS was analyzed for DTC overall, and for PTC and FTC separately, using several age cutoffs (per 5-year increment between 20 and 85 years and subsequently 1-year increments between 35 and 55 years), employing the histopathological criteria from the TNM staging system, eighth edition. Results: We included 3074 DTC patients (77% PTC and 23% FTC; mean age at diagnosis was 49 years). Median follow-up was seven years. For DTC and for PTC and FTC separately, the majority of the age cutoffs had a better statistical model performance than a model with no age cutoff. For DTC overall and for PTC, an age cutoff of 50 years had the best statistical model performance, while it was 40 years for FTC. Conclusions: In this large European population of DTC patients, when employing the histopathological criteria of the TNM system (eighth edition), the optimal age cutoff to predict DSS is 50 years rather than the 55 years currently in use. With the optimal age cutoff being 50 years for PTC and 40 years for FTC, there was a substantial difference in age cutoff for the respective histological entities. Therefore, implementation of different age cutoffs for PTC and FTC could improve the predictive value of the TNM staging system.